Polygenic Risk Scores & the Future of Precision Medicine: Challenges and Opportunities

On demand webinar

Dr. George Busby, CSO & Co-founder of Allelica (300 × 214 px) (1920 × 800 px) (1920 × 1080 px)

9 September 2021 

Discover the role of Polygenic Risk Score (PRS) in advanced genomic risk assessment and precision healthcare in the UK.

In this webinar, experts explore the current clinical application of PRS, future opportunities, and the obstacles to widespread adoption. Dr. Nick Lench, CSO at Congenica, and Dr. George Busby, CSO at Allelica, discuss innovative applications for scalable genomic risk analysis of common diseases.

During this webinar, you will learn about:

  • The latest developments in Polygenic Risk Score research and clinical application
  • Advances in genomic risk assessments for common diseases like breast cancer
  • Emerging technologies available for PRS application at scale.

Enter your details to watch this complimentary webinar
CE 60px-Conformité_Européenne - WHITEISO 27001 Certified British Assessment Bureau - Certificate No. 205723 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2022 Congenica Ltd, Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.